Oncocross Co., Ltd. (KOSDAQ:382150)
South Korea · Delayed Price · Currency is KRW 9,330.00
+220.00 (2.41%)
Aug 14, 2025, 3:30 PM KST
Oncocross Market Cap
Oncocross has a market cap or net worth of 112.13 billion as of August 15, 2025.
Market Cap
112.13B
Enterprise Value
95.54B
Revenue
1.07B
Ranking
n/a
PE Ratio
n/a
Stock Price
9,330.00
Market Cap Chart
Since December 18, 2024, Oncocross's market cap has increased from 106.25B to 112.13B, an increase of 5.53%. That is a compound annual growth rate of 8.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2025 | 112.13B | 49.15% |
| Dec 30, 2024 | 75.18B | -29.24% |
| Dec 18, 2024 | 106.25B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 73.52T |
| Celltrion | 38.58T |
| ALTEOGEN | 23.35T |
| Yuhan | 8,561.74B |
| Peptron | 8,235.61B |
| SK Biopharmaceuticals | 7,878.31B |
| PharmaResearch | 7,106.52B |
| LigaChem Biosciences | 5,666.20B |